Published on 2/06/2020 12:30:44 PM | Source: Dion Global Solutions Ltd

Marksans Pharma Q4 net profit up 31.85% at Rs 7.41 cr

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel 

Download Telegram App before Joining the Channel

The company reported standalone net profit of Rs 7.41 crore for the quarter ended March 31, 2020 as compared to Rs 5.62 crore in the same period last year, registering a year-on-year growth of 31.85 per cent.

Net revenue of the company rose substantially by 24.63 per cent at Rs 113.64 crore in January-March quarter of this fiscal as against Rs 91.18 crore in the corresponding period last year. During January-March quarter, operating expenses increased by 8.49 per cent to Rs 95.25 crore from Rs 87.80 crore in year ago period. Other Income dipped by 100.84 per cent at Rs -0.08 crore versus (Mar'19 Rs 9.50 crore).

Operating Profit surged by 444.08 per cent to Rs 18.39 crore as against Rs 3.38 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 336.12 per cent in March quarter. Interest declined by 9.24 per cent y-o-y to Rs 1.67 crore, while Taxation increased by 80.00 per cent at Rs 5.76 crore (Mar'19 Rs 3.20 crore).